OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹86 Cr | ₹34 Cr | ₹33 Cr | ₹8.07 Cr | ₹17 Cr |
What is the latest Total Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹8.07 Cr |
| Mar2021 | ₹17 Cr |
How is Total Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 154.78 | |
| Mar2024 | ₹34 Cr | 2.42 | |
| Mar2023 | ₹33 Cr | 307.76 | |
| Mar2022 | ₹8.07 Cr | -53.89 | |
| Mar2021 | ₹17 Cr | - | |
Compare Total Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹174.8 Cr | -2.6% | -6.8% | -61.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -2.6% |
-6.8% |
-61.3% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses